ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Zealand Pharma AS

Zealand Pharma AS (22Z)

97.50
-2.50
(-2.50%)
Closed November 26 3:00PM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
97.50
Bid
97.05
Ask
97.95
Volume
477
94.50 Day's Range 100.20
42.68 52 Week Range 132.50
Previous Close
100.00
Open
99.95
Last Trade
40
@
97.2
Last Trade Time
Average Volume (3m)
1,675
Financial Volume
-
VWAP
-

22Z Latest News

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Company announcement – No. 50 / 2024...

Zealand Pharma Announces Financial Results for the First Nine Months of 2024

Zealand Pharma Announces Financial Results for the First Nine Months of 2024 Company announcement – No. 49 / 2024 Zealand Pharma Announces Financial Results for the First Nine Months of 2024...

Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism

Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism Company announcement – No. 48 / 2024 Zealand Pharma provides U.S. regulatory update on dasiglucagon in...

Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide

Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide Company announcement – No. 47 / 2024 Zealand...

Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024

Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024 Company announcement – No. 46 / 2024 Total number of shares and voting rights in Zealand Pharma A/S on...

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Company announcement – No. 45 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of...

Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide

Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Company announcement – No. 44 /...

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Company announcement – No. 43 / 2024...

Total number of shares and voting rights in Zealand Pharma on August 30, 2024

Total number of shares and voting rights in Zealand Pharma on August 30, 2024 Company announcement – No. 42 / 2024 Total number of shares and voting rights in Zealand Pharma on August 30, 2024...

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Company announcement – No. 41 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
17.558.3935519733289.95100.689.05127994.18241827DE
4-13-11.7647058824110.5119.588.051641103.84975173DE
12-18.1-15.6574394464115.6124.588.051675108.65392489DE
2618.0522.718691000679.45132.578.452321109.99720169DE
5254.34125.90361445843.16132.542.68268795.31751443DE
15662.96182.28141285534.54132.534.04220094.73205856DE
26062.96182.28141285534.54132.534.04220094.73205856DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
2RZPoseida Therapeutics Inc
8.90 €
(225.77%)
48.28k
GMEGeratherm Medic
5.55 €
(83.77%)
91.55k
7S2Scotch Creek Ventures Inc
0.0144 €
(67.44%)
100k
ZN80Hesai Group
7.20 €
(59.29%)
37.64k
AXIAtos SE
0.595 €
(57.62%)
3.04M
CHPCitigold Corporation Ltd
0.001 €
(-60.00%)
250k
L7C2Windfall Geotek Inc
0.0025 €
(-54.55%)
500
QN90Military Metals Corp
0.278 €
(-36.53%)
324.13k
PKTMPIERER Mobility AG
9.06 €
(-35.74%)
173.35k
0Z2Alector Inc
2.44 €
(-35.45%)
34.44k
R1EAEV Resources Ltd
0.002 €
(25.00%)
4.8M
D7GNel ASA
0.272 €
(1.12%)
3.14M
AXIAtos SE
0.595 €
(57.62%)
3.04M
PF8European Lithium Limited
0.0168 €
(0.00%)
2.96M
3CPXiaomi Corporation
3.2835 €
(-5.40%)
2.09M

Discussion

View Full Feed
BDEZ BDEZ 5 minutes ago
Thanks georgie..
XRPUSD
$GROO $GROO 6 minutes ago
Never Quit $SANP
Never Quit $SANP $GROO ht
GROO SANP
Oleblue Oleblue 6 minutes ago
In this solo lecture, Chris Miller, author of the acclaimed book "Chip War", delves into the intricate world of semiconductors, exploring how microchips have become the cornerstone of global power and economic influence. Miller will provide an analysis of the geopolitical ramifications of semiconduc
NVDA
JettaR JettaR 8 minutes ago
No one is "rooting" for the stock to go down.  Eyes wide open. Eyes wide open. It's right on front of everyone. 
RGLG
lambchops lambchops 8 minutes ago
Peeps ought to gobble up some NFTM shares for gobble-gobble day!

Eat turkey--not lamb-- on Christmas! Yum-yum.

Happy T-bird day. And remember,"Fun. Fun, fun till your daddy takes the T-bird awayNFTM
NFTM
reaper247 reaper247 10 minutes ago
Always good to hear from ya Drugdoctor.

I suspect we have a few people lurking around.

Hope all GVSIers have as safe and happy Thanksgiving.

GLTA, IMO and FWIW.
GVSI
jondoeuk jondoeuk 10 minutes ago
One for FT819 as well https://www.globenewswire.com/news-release/2024/11/18/2982757/24675/en/Fate-Therapeutics-Presents-6-Month-Follow-up-Data-on-First-Patient-Treated-in-Phase-1-Autoimmunity-Study-with-Fludarabine-free-Conditioning-and-FT819-Off-the-shelf-1XX-CAR-T-cell-P.html
FATE
skitahoe skitahoe 11 minutes ago
NWBO is in a similar situation in the EU. I believe that you'll find that the 150 days doesn't begin with submission. No one is absolutely certain, some believed it started with preliminary validation, which occurred roughly a month after submission. Others believed it began with final validation
AVXL NWBO
jjjjjjjj jjjjjjjj 11 minutes ago
Gummies for dummies -- yummies , LMAO burger flipper
Reply privately from blusher.

Keep doing the 2 steps:
1. SET SELL HIGH our shares.
2. SET BUY HIGHssssssss with last minute and price limit.

MJNA is a good company. Best to us longs.
MJNA
jondoeuk jondoeuk 11 minutes ago
The PR https://www.globenewswire.com/news-release/2024/11/18/2982736/24675/en/Fate-Therapeutics-Highlights-FT522-Off-the-shelf-ADR-armed-CAR-NK-Cell-Product-Candidate-at-2024-ACR-Convergence.html
FATE
gfp927z gfp927z 13 minutes ago
Xena, All I said was that a B-12 deficiency might be the cause of your advancing foot numbness. Gadolinium toxicity might have the same effect (?), but logic says to eliminate other obvious possibilities before concluding that it is the gadolinium.

>> given the level of supplementa
jondoeuk jondoeuk 14 minutes ago
They need to pick up the pace of enrolment. If they don't see activity at DL2, I think it could be in trouble.
FATE
Plato_ Plato_ 18 minutes ago
https://investorshub.advfn.com/uimage/uploads/2024/11/27/hcolltrade-error-314217-the-share-quanitty-is-limited.png
Source: https://www.reddit.com/r/fidelityinvestments/comments/1grxuld/comment/ly9voew

FYI. Found this on a subreddit regarding Fidelity restrictions on trade size.
GDVM
gimmegimmeminemine gimmegimmeminemine 20 minutes ago
At a bare minimum, I want to see viable proof that they have solved the issue of mass scale production, cost effectively on a quality consistent basis.
Clear and consice viable proof.

I would be ecstatic if they are ready or already putting out product on a regular basis, be i
KBLB
rrflyboy rrflyboy 20 minutes ago
"Phunware Loss Causation Decision Dismissing The MTD With No Prejudice to Determining Still Longer Term Damage"
Thanks for the info dbing, finally a bit of sunshine may appear.
Same court, same issues, same law firm and the same plaintiff's attorney, Posner, as the NWBO case. Not sure
NWBO
jondoeuk jondoeuk 20 minutes ago
Big volume into the close, over 12 million. Someone knows something.
FATE
dinogreeves dinogreeves 21 minutes ago
Just Wow. Some reason I knew this was coming.

Now we wait to see this strategic move

Going private? Maybe, then why file for extension or even hire an auditor, was this a last minute decision?

Buyout offer on the table? Who knows

Merger
SMCI
XenaLives XenaLives 21 minutes ago
The short whores are out in force tonight.

It seems that capitulation of short interest is imminent....


HOLD..

HOLD....

HOLD .......


NOW !!!!!



https://www.youtube.com/watch?v
LWLG
jimmy051357 jimmy051357 21 minutes ago
Do you think the decision to set this up to transition on Dec 30 was an accident?
SANP
DJPele DJPele 22 minutes ago
https://x.com/hoffmann6383/status/1861618491058491410

Breaking News: Federal Court Allows Second Spoofing Case against Market Maker to Proceed

The Case: Phunware Inc. v. UBS Securities, LLC, 1:23-cv-06426 (SDNY)

Plaintiff: $PHUN
Defendant:
NWBO PHUN UBS
hardlesson hardlesson 22 minutes ago
You might not want to lump me in to "everyone." You had shares until today, when you flip flopped again over your fears of tax loss sellers.

Your playbook is cyclical, and predictable. See you in the morning with your amusing bid whacks, because we both know you've saved some.
SHMN
dinogreeves dinogreeves 23 minutes ago
"On November 20, 2024, Super Micro Computer, Inc. (the “Company”) prepaid in full and terminated its obligations under each of (i) the Loan Agreement, by and among the Company and Cathay Bank, as amended or otherwise modified, and (ii) the Loan and Security Agreement with Bank of America N.A., by an
SMCI
TrendTrade2016 TrendTrade2016 25 minutes ago
Another China monster and the clowns missed it as always
HSAI
TrendTrade2016 TrendTrade2016 26 minutes ago
KDLY beautiful run
KDLY
holter49 holter49 27 minutes ago
It has been a month and Patrick has been quiet. What does that say for the company performance?
MLRT

Your Recent History

Delayed Upgrade Clock